Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)
Clinical trial NCT02579239 · COMPLETED
Trial details
- NCT number
- NCT02579239
- Sponsor
- aTyr Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-30
- Primary completion
- 2016-10-05
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.